110 related articles for article (PubMed ID: 3409835)
1. [Activity of the natural killer cells in the peripheral blood of patients with brain tumors].
Lisianyĭ NI; Markova OV; Zhmareva EN
Eksp Onkol; 1988; 10(3):57-9. PubMed ID: 3409835
[TBL] [Abstract][Full Text] [Related]
2. [Cellular immunity in human brain tumours (author's transl)].
Böker DK
Neurochirurgia (Stuttg); 1980 Nov; 23(6):229-34. PubMed ID: 7442895
[TBL] [Abstract][Full Text] [Related]
3. Autologous natural killer cell therapy for human recurrent malignant glioma.
Ishikawa E; Tsuboi K; Saijo K; Harada H; Takano S; Nose T; Ohno T
Anticancer Res; 2004; 24(3b):1861-71. PubMed ID: 15274367
[TBL] [Abstract][Full Text] [Related]
4. [Lymphocyte subpopulations and their functional activity in patients with brain tumors].
Rudenko VA; Lisianyĭ NI; Radzievskiĭ AA
Vrach Delo; 1990 Sep; (9):91-4. PubMed ID: 2284786
[TBL] [Abstract][Full Text] [Related]
5. [Changes of natural killer activity following local 60Co irradiation in intracranial tumor-bearing mice (author's transl)].
Otsuka S; Suda K; Yamashita J; Takeuchi J; Handa H
No To Shinkei; 1982 Apr; 34(4):393-8. PubMed ID: 7093076
[TBL] [Abstract][Full Text] [Related]
6. Natural killer cells in meningiomas.
Vaquero J; Coca S; Pontón P; Oya S; Arias A
Histol Histopathol; 1991 Jul; 6(3):369-72. PubMed ID: 1810535
[TBL] [Abstract][Full Text] [Related]
7. [Immunosuppressive activity of the serum in patients with brain tumors and various neurological disorders--anti-sheep red blood cell plaque-forming cell response in mouse spleens (author's transl)].
Iwaki K
Nihon Geka Hokan; 1981 Nov; 50(6):796-808. PubMed ID: 7039545
[No Abstract] [Full Text] [Related]
8. In vitro demonstration of cell-mediated immunity to human brain tumors.
Levy NL; Mahaley MS; Day ED
Cancer Res; 1972 Mar; 32(3):477-82. PubMed ID: 4334410
[No Abstract] [Full Text] [Related]
9. [Detection of natural killer cells activity in patients with laryngeal carcinoma using the 51Cr release assay].
Yang YB
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1990; 25(1):42-4, 63. PubMed ID: 2363975
[TBL] [Abstract][Full Text] [Related]
10. [Improvement of host-immunity by adjuvant therapy with juzen-taiho-to for patients with brain tumors].
Miyagami M; Katayama Y
No Shinkei Geka; 2003 Apr; 31(4):401-9. PubMed ID: 12704821
[TBL] [Abstract][Full Text] [Related]
11. [Changes in NK cell activity in patients with acute leukemia].
Soucek J; Sedlácková M; Lindnerová G
Cas Lek Cesk; 1990 Oct; 129(43):1345-8. PubMed ID: 2249230
[TBL] [Abstract][Full Text] [Related]
12. [The effect of sera of breast cancer patients on NK cell activity].
Konjević G; Spuzić I
Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
[TBL] [Abstract][Full Text] [Related]
13. The determination of natural killer activity of human peripheral blood lymphocytes by measuring the DNA-synthesis of proliferating target cells (K 562 cell line).
Huttunen K; Ilonen J
Acta Pathol Microbiol Immunol Scand C; 1983 Jun; 91(3):197-201. PubMed ID: 6880751
[TBL] [Abstract][Full Text] [Related]
14. Functional analysis of interleukin-2 in immune surveillance against brain tumors.
Yoshida S; Takai N; Tanaka R
Neurosurgery; 1987 Nov; 21(5):627-30. PubMed ID: 3501073
[TBL] [Abstract][Full Text] [Related]
15. [Immunological monitoring of brain tumors--prognosis and cellular immunity of patients with brain tumors].
Yokoyama H; Hara M; Ogashiwa M; Takeuchi K
No To Shinkei; 1983 Nov; 35(11):1103-8. PubMed ID: 6661336
[TBL] [Abstract][Full Text] [Related]
16. Impaired thymus-derived lymphocyte function in patients with malignant brain tumour.
Menzies CB; Gunar M; Thomas DG; Behan PO
Clin Neurol Neurosurg; 1980; 82(3):157-68. PubMed ID: 6260411
[TBL] [Abstract][Full Text] [Related]
17. Natural killer cell activity in families of patients with systemic lupus erythematosus: demonstration of a killing defect in patients.
Green MR; Kennell AS; Larche MJ; Seifert MH; Isenberg DA; Salaman MR
Clin Exp Immunol; 2005 Jul; 141(1):165-73. PubMed ID: 15958083
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory infiltrates and natural killer cell presence in human brain tumors.
Stevens A; Klöter I; Roggendorf W
Cancer; 1988 Feb; 61(4):738-43. PubMed ID: 3338036
[TBL] [Abstract][Full Text] [Related]
19. Specific cellular immune responses in patients with malignant gliomas.
Sheikh KM; Apuzzo ML; Weiss MH
Cancer Res; 1979 May; 39(5):1733-8. PubMed ID: 85487
[TBL] [Abstract][Full Text] [Related]
20. [Natural killer activity of peripheral blood lymphocytes in patients with brain tumors].
Otsuka S; Suda K; Yamashita J; Takeuchi J; Handa H
No Shinkei Geka; 1982 Dec; 10(12):1291-7. PubMed ID: 7170068
[No Abstract] [Full Text] [Related]
[Next] [New Search]
